image: Bile acid remodeling during liver aging. The schematic connects altered uptake, synthesis, receptor feedback and export with bile acid accumulation, oxidative stress and lipid deposition. The pattern and magnitude of changes vary across biological contexts.
Credit: HIGHER EDUCATION PRESS
How can bile acids help maintain metabolic balance and regulate inflammation, yet damage the liver when they accumulate? Synthesized from cholesterol, bile acids aid fat digestion and absorption and signal through receptors involved in metabolism and immunity. Aging changes their synthesis, transport and microbial transformation. In a review published in Life Medicine on 7 August 2026, Ming He, Yinkun Fu and collaborators at Shanghai Jiao Tong University School of Medicine examine how these changes influence susceptibility to liver disease.
The description of bile acids as a “new hormone” refers to their hormone-like functions, not the discovery of a single new hormone. Bile acids enter the intestine through bile and return to the liver through enterohepatic circulation, while gut microbes generate molecules with different biological activities. Their signaling effects therefore depend on bile acid species, conjugation state, concentration and tissue environment.
Two major signaling hubs are the nuclear receptor FXR and the membrane receptor TGR5 (GPBAR1). FXR pathways in the liver and intestine help regulate bile acid synthesis and circulation, while TGR5 participates in energy metabolism, incretin secretion and inflammatory responses. Comparing receptor preferences of representative bile acids shows why total bile acid measurements alone cannot capture their biological functions.
Aging and bile acid imbalance are linked in both directions. Age-associated changes in bile acid synthesis, transport and receptor responsiveness reshape the bile acid pool. In turn, abnormal accumulation or reduced protective signaling may worsen mitochondrial and endoplasmic reticulum stress, oxidative injury and chronic inflammation (Figure 1). These changes vary with sex, diet, metabolic status and microbial composition. Lithocholic acid and its derivatives show this complexity: potential benefits in some experimental models coexist with hepatotoxicity when lithocholic acid accumulates. These findings do not establish that bile acid supplementation slows human aging.
Host and microbial processes jointly shape bile acid activity. Microbial bile salt hydrolases deconjugate bile acids, and 7α-dehydroxylating bacteria convert cholic acid and chenodeoxycholic acid into deoxycholic acid and lithocholic acid. These transformations alter hydrophobicity, receptor selectivity and enterohepatic recycling, while bile acids also influence microbial communities and the intestinal barrier. During aging, microbial changes may reshape FXR and TGR5 signaling; impaired barrier function can increase translocation of microbial products to the liver and amplify chronic inflammation.
The review examines chronic hepatitis B, autoimmune liver diseases, alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma in the context of aging. In hepatitis B, the bile acid transporter NTCP also serves as a viral entry receptor. Autoimmune liver diseases involve cholestasis, immune regulation and gut microbes. Alcohol-associated disease involves disrupted enterohepatic circulation, oxidative stress and abnormal autophagy. In metabolic liver disease, associations between specific bile acid components, ratios and disease severity remain heterogeneous.
In hepatocellular carcinoma, bile acid toxicity, inflammation and receptor signaling depend on disease stage. TGR5 can exert protective effects in inflammatory settings, whereas its signaling may be co-opted in established tumors (Figure 2). These contrasting roles show why a receptor cannot be classified as consistently beneficial or harmful without considering cellular and disease context.
Potential approaches include FXR/TGR5 modulation, bile acid sequestration, hydrophilic bile acids and microbiota-directed interventions. Their evidence bases differ, and their suitability for older adults requires assessment alongside frailty, cholestasis, kidney function, concurrent medications and microbial differences. A key task is to distinguish accompanying biomarkers from bile acid changes that causally influence liver aging or injury. Longitudinal human studies, bile acid profiling stratified by age and sex, and cross-species and intervention studies could help resolve this question.
Journal
Life Medicine
Method of Research
Experimental study
Subject of Research
Not applicable
Article Title
Bile acids as a “new hormone” in aging-related liver disease
Article Publication Date
7-Aug-2026